{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:57:28Z","timestamp":1788371848949,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"DOI":"10.7759\/cureus.98556","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:41:09Z","timestamp":1765006869000},"source":"Crossref","is-referenced-by-count":1,"title":["Herpes Zoster (HZ) Over the Past 10 Years: A Systematic Review on Trends, Triggers, and Post-COVID-19 Impact"],"prefix":"10.7759","author":[{"given":"Kahina","family":"Dameche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha s","family":"AlMesallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15521","article-title":"Herpes zoster in the era of COVID 19: a prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination","volume":"35","author":"Almutairi N","year":"2022","unstructured":"Almutairi N, Almutairi AN, Almazyad M, Alwazzan S. Herpes zoster in the era of COVID 19: a prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination. Dermatol Ther. 2022, 35:e15521. 10.1111\/dth.15521","journal-title":"Dermatol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28745","article-title":"Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2\u2009442\u2009686 patients","volume":"95","author":"Chen YC","year":"2023","unstructured":"Chen YC, Ho CH, Liu TH, Wu JY, Huang PY, Tsai YW, Lai CC. Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2\u2009442\u2009686 patients. J Med Virol. 2023, 95:e28745. 10.1002\/jmv.28745","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-021-01286-4","article-title":"Cognitive decline following acute viral infections: literature review and projections for post-COVID-19","volume":"272","author":"Damiano RF","year":"2022","unstructured":"Damiano RF, Guedes BF, de Rocca CC, et al.. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci. 2022, 272:139-54. 10.1007\/s00406-021-01286-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01323-9","article-title":"Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection","volume":"47","author":"G\u00e1sp\u00e1r Z","year":"2025","unstructured":"G\u00e1sp\u00e1r Z, Szab\u00f3 BG, Cegl\u00e9di A, Lakatos B. Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection. Geroscience. 2025, 47:167-87. 10.1007\/s11357-024-01323-9","journal-title":"Geroscience"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.53350\/pjmhs2216196","article-title":"Herpes zoster post Covid-19 vaccination","volume":"16","author":"Hafeez J","year":"2022","unstructured":"Hafeez J, Malik SS, Bashir U, Hafeez A, Naheed A, Naveed T. Herpes zoster post Covid-19 vaccination. Pak J Med Health Sci. 2022, 16:96-8. 10.53350\/pjmhs2216196","journal-title":"Pak J Med Health Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.58775\/2735-3990.1415","article-title":"Increasing incidence and unusual presentations of chickenpox infection in the post COVID-19 era in Egypt","volume":"53","author":"Hamdy S","year":"2024","unstructured":"Hamdy S, Awad A. Increasing incidence and unusual presentations of chickenpox infection in the post COVID-19 era in Egypt. Mans Med J. 2024, 53:10.58775\/2735-3990.1415","journal-title":"Mans Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2256047","article-title":"Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020-2021)","volume":"19","author":"Irigoyen-Mansilla VM","year":"2023","unstructured":"Irigoyen-Mansilla VM, Gil-Prieto R, Gea-Izquierdo E, Barrio-Fern\u00e1ndez JL, Hern\u00e1ndez-Barrera V, Gil-de-Miguel A. Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020-2021). Hum Vaccin Immunother. 2023, 19:2256047. 10.1080\/21645515.2023.2256047","journal-title":"Hum Vaccin Immunother"},{"key":"ref8","article-title":"Herpes zoster in the context of the SARS-CoV-2 pandemic: multiple triggers for a latent infection","volume":"11","author":"Norberg A","year":"2021","unstructured":"Norberg A, Norberg PR, Norberg CM, et al.. Herpes zoster in the context of the SARS-CoV-2 pandemic: multiple triggers for a latent infection. World J Pharm Pharm Sci. 2021, 11:43-62.","journal-title":"World J Pharm Pharm Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1200353","article-title":"COVID-19 and herpes zoster: a call to action","volume":"11","author":"Noushad M","year":"2023","unstructured":"Noushad M, Nassani MZ, Samran A, Dimashkieh MR, Al-Awar MS. COVID-19 and herpes zoster: a call to action. Front Public Health. 2023, 11:1200353. 10.3389\/fpubh.2023.1200353","journal-title":"Front Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00924-3","article-title":"The impact of the COVID-19 pandemic on the incidence of herpes zoster: a narrative literature review","volume":"13","author":"Parikh R","year":"2024","unstructured":"Parikh R, Yousefi M, Curran D, Widenmaier R. The impact of the COVID-19 pandemic on the incidence of herpes zoster: a narrative literature review. Infect Dis Ther. 2024, 13:447-61. 10.1007\/s40121-024-00924-3","journal-title":"Infect Dis Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref12","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2011). https.\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn Z","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, et al.. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020, 18:2127-33. 10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2046795","article-title":"Manifestation of herpetic eye disease after COVID-19 vaccine: a UK case series","volume":"30","author":"Rallis KI","year":"2022","unstructured":"Rallis KI, Fausto R, Ting DS, Al-Aqaba MA, Said DG, Dua HS. Manifestation of herpetic eye disease after COVID-19 vaccine: a UK case series. Ocul Immunol Inflamm. 2022, 30:1136-41. 10.1080\/09273948.2022.2046795","journal-title":"Ocul Immunol Inflamm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2891711\/v1","article-title":"Increasing rates of herpes zoster ophthalmicus and the COVID-19 pandemic [PREPRINT]","author":"Snyder AJ","year":"2023","unstructured":"Snyder AJ, Mousa HM, Soifer M, Jammal AA, Aggarwal S, Perez VL. Increasing rates of herpes zoster ophthalmicus and the COVID-19 pandemic [PREPRINT]. Res Sq. 2023, 10.21203\/rs.3.rs-2891711\/v1","journal-title":"Res Sq"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/430407-herpes-zoster-hz-over-the-past-10-years-a-systematic-review-on-trends-triggers-and-post-covid-19-impact","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:41:11Z","timestamp":1765006871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/430407-herpes-zoster-hz-over-the-past-10-years-a-systematic-review-on-trends-triggers-and-post-covid-19-impact"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.98556","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}